MedPath

A Multicenter Single-blind Comparison Between Standard and Individualized Approach in Bowel Preparation Before Colonoscopy

Phase 4
Completed
Conditions
Bowel Cleansing Process
Colonoscopy
Interventions
Drug: Standard approach
Drug: Individualized approach
Registration Number
NCT02024022
Lead Sponsor
Clinical Hospital Colentina
Brief Summary

This study aims to compare a standard approach to bowel preparation for colonoscopy (using sodium picosulphate/magnesium citrate or 4lPEG) to an individualized approach where patients are assigned a specific regimen of either sodium picosulphate/magnesium citrate or 4lPEG depending on patient-related factors. The study aims to compare patient-related outcomes such as comfort levels during bowel cleansing and physician-related outcomes such as bowel prep quality in the two study groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
185
Inclusion Criteria
  • all patients > 18 years of age undergoing elective colonoscopy on an outpatient basis
Exclusion Criteria
  • refusal to sign informed consent
  • pregnancy
  • advance kidney, liver or heart disease
  • suspicion of malignant / benign stenosis of the digestive tract

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard approachStandard approachpatients will be randomized to one of the 2 currently used bowel preparation regimens in our clinic: * 4L split polyethylene glycol solution * split magnesium citrate/sodium picosulphate preparation regimen
Individualized approachIndividualized approachpatients will receive either the 4L split polyethylene glycol bowel prep regimen or the sodium picosulphate/magnesium citrate split prep regimen according to personal characteristics assessed using a self-administered questionnaire (including bowel habits, the preference for large-volume preparation and education level)
Primary Outcome Measures
NameTimeMethod
bowel cleansing24 hours

bowel cleansing as assessed during colonoscopy using 2 assessment scales (Boston bowel prep scale, and a 1-4 semiquantitative scale)

Secondary Outcome Measures
NameTimeMethod
patient comfort level during bowel cleansing24 hours

patient pain levels on a 0-10 visual analogue scale during the bowel cleansing process

Trial Locations

Locations (3)

Colentina Clinical Hospital

🇷🇴

Bucharest, Romania

Institutul Regional de Gastroenterologie si Hepatologie prof. dr. Octavin Fodor

🇷🇴

Cluj, Romania

Spitalul CFR

🇷🇴

Cluj, Romania

© Copyright 2025. All Rights Reserved by MedPath